NCT06834672 Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Status RECRUITING Phase PHASE3
NCT06787807 Proteomic Analysis of Patients Undergoing Bariatric Surgery Status NOT_YET_RECRUITING Phase NA
NCT02734004 A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02331251 Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) Status TERMINATED Phase PHASE1/PHASE2
NCT01078662 Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats Status COMPLETED Phase PHASE2
NCT00972205 Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors Status COMPLETED Phase NA
NCT00888810 Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer Status TERMINATED Phase PHASE2
NCT00423254 Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. Status COMPLETED Phase PHASE1